Clover Health Investments Price to Free Cash Flow Ratio 2020-2025 | CLOV

Historical price to free cash flow ratio values for Clover Health Investments (CLOV) since 2020. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Clover Health Investments Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-05-20 3.69 0.00
2025-03-31 3.59 $-0.02 0.00
2024-12-31 3.15 $0.07 46.39
2024-09-30 2.82 $-0.29 0.00
2024-06-30 1.23 $-0.43 0.00
2024-03-31 0.79 $-0.39 0.00
2023-12-31 0.95 $-0.30 0.00
2023-09-30 1.08 $-0.21 0.00
2023-06-30 0.90 $0.04 22.54
2023-03-31 0.85 $-0.18 0.00
2022-12-31 0.93 $-0.44 0.00
2022-09-30 1.70 $-0.19 0.00
2022-06-30 2.14 $-0.50 0.00
2022-03-31 3.55 $-0.56 0.00
2021-12-31 3.72 $-0.69 0.00
2021-09-30 7.39 $-1.59 0.00
2021-06-30 13.15 $-1.63 0.00
2021-03-31 7.46 $-1.59 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.832B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.988B 53.85
Hims & Hers Health (HIMS) United States $13.954B 144.98
Tempus AI (TEM) United States $10.977B 0.00
IRhythm Technologies (IRTC) United States $4.526B 0.00
Inspire Medical Systems (INSP) United States $4.418B 69.02
Privia Health (PRVA) United States $3.048B 208.33
Enovis (ENOV) United States $2.027B 11.30
Schrodinger (SDGR) United States $1.721B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.305B 23.02
Azenta (AZTA) United States $1.242B 57.70
10x Genomics (TXG) United States $1.100B 0.00
Fulgent Genetics (FLGT) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.574B 0.00
Talkspace (TALK) United States $0.504B 150.50
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.452B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.376B 834.00
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.231B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.134B 0.00
American Well (AMWL) United States $0.114B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.088B 3.34
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.068B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00